Aha | Eptifibatide |
Nọmba CAS | 188627-80-7 |
Usoro ihe omimi | C35H49N11O9S2 |
Ibu molekụla | 831.96 |
Nọmba EINECS | 641-366-7 |
Njupụta | 1.60±0.1 g/cm3 (buru amụma) |
Ọnọdụ nchekwa | E mechiri ya na nkụ, chekwaa ya na friza, n'okpuru -15 Celsius |
Eptifibatideacetatesalt;Eptifibatide,MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2,MPAHARGDWPC-NH2,>99%;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide; (Aminoiminomethyl) -N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-La-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2 (DISULFIDEBRIDGE,MPA1-CYS6).
Etifibatide (integrilin) bụ akwụkwọ akụkọ polypeptide platelet glycoprotein IIb/IIIa antagonist nke na-egbochi nchịkọta platelet na thrombosis site na igbochi ụzọ ikpeazụ nke nchịkọta platelet.E jiri ya tụnyere monoclonal antibody abciximab, eptifibatide nwere njikọ siri ike karị, ntụzịaka na nke kapịrị ọnụ na GPIIb/IIIa n'ihi ịdị adị nke otu nnọchi amino acid conservative-lysine iji dochie arginine.Ya mere, ọ kwesịrị inwe mmetụta ọgwụgwọ dị mma na ntinye aka nke nnukwu ọrịa ọrịa obi.Platelet glycoprotein IIb/IIIa emepụtala ọgwụ ndị na-anabata ndị na-anabata ya nke ukwuu, ma ugbu a enwere ụdị nkwadebe atọ nwere ike iji na ụlọ ọgwụ na mba ụwa, abciximab, eptifibatide na tirofiban.).Enweghi ahụmịhe dị nta n'iji platelet glycoprotein GPIIb/IIa ndị na-emegide ndị na-anabata ihe na China, yana ọgwụ ndị dịnụ nwekwara oke oke.Naanị otu ọgwụ, tirofiban hydrochloride, dị n'ahịa.Ya mere, e mepụtara platelet glycoprotein IIb ọhụrụ./IIIa ndị na-emegide ndị na-anabata ya dị mkpa.Eptifibatide ụlọ bụ ngwaahịa nṅomi nke Chengdu Sino Biological Products Co., Ltd mepụtara.
Nhazi nke ọgwụ nchịkọta Antiplatelet
Enwere ike kewaa ọgwụ mgbochi antiplatelet ụzọ atọ: 1. Cyclooxygenase-1 (COX-1) inhibitors, dị ka aspirin.2. Na-egbochi nchịkọta platelet na-akpata site na adenosine diphosphate (ADP), dị ka clopidogrel, prasugrel, cangrelor, ticagrelor, wdg. prostaglandin EP3 receptor inhibitors, ihe mejupụtara kemịkalụ ọhụrụ na mpụta dị irè sitere na ọgwụ ndị China ọdịnala.